- Home
- TXMD vs GNLN Comparison
TXMD vs GNLN Comparison
Compare TXMD & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- GNLN
- Stock Information
- Founded
- TXMD 2008
- GNLN 2005
- Country
- TXMD United States
- GNLN United States
- Employees
- TXMD N/A
- GNLN N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- GNLN Durable Goods
- Sector
- TXMD Health Care
- GNLN Consumer Discretionary
- Exchange
- TXMD Nasdaq
- GNLN Nasdaq
- Market Cap
- TXMD 13.5M
- GNLN 12.9M
- IPO Year
- TXMD N/A
- GNLN 2019
- Fundamental
- Price
- TXMD $1.14
- GNLN $3.46
- Analyst Decision
- TXMD
- GNLN
- Analyst Count
- TXMD 0
- GNLN 0
- Target Price
- TXMD N/A
- GNLN N/A
- AVG Volume (30 Days)
- TXMD 30.4K
- GNLN 2.1M
- Earning Date
- TXMD 07-30-2025
- GNLN 08-13-2025
- Dividend Yield
- TXMD N/A
- GNLN N/A
- EPS Growth
- TXMD N/A
- GNLN N/A
- EPS
- TXMD N/A
- GNLN N/A
- Revenue
- TXMD $1,841,000.00
- GNLN $9,818,000.00
- Revenue This Year
- TXMD $427.09
- GNLN $1,541.21
- Revenue Next Year
- TXMD N/A
- GNLN N/A
- P/E Ratio
- TXMD N/A
- GNLN N/A
- Revenue Growth
- TXMD 53.55
- GNLN N/A
- 52 Week Low
- TXMD $0.70
- GNLN $2.84
- 52 Week High
- TXMD $2.44
- GNLN $16,350.00
- Technical
- Relative Strength Index (RSI)
- TXMD 43.84
- GNLN 31.48
- Support Level
- TXMD $1.07
- GNLN $2.88
- Resistance Level
- TXMD $1.24
- GNLN $3.80
- Average True Range (ATR)
- TXMD 0.08
- GNLN 0.72
- MACD
- TXMD 0.00
- GNLN 1.19
- Stochastic Oscillator
- TXMD 59.62
- GNLN 12.96
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.